Quipt Home Medical (QIPT) said Tuesday it has signed a cooperation deal with David Kanen, Philotimo Fund, and Kanen Wealth Management under which Kanen agreed to withdraw its notice about its intent to seek proxies in support of four director candidates at Quipt's upcoming annual general meeting.
As part of the deal, Kanen gets certain board access rights as long as it keeps a total beneficial stake of at least 3.5% in Quipt, the company said.
Quipt said it also agreed to create a new board committee to offer non-binding recommendations regarding Kanen's suggestions related to corporate governance and other areas of the company's operations.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。